DECIPHERING AND TARGETING EZH2 OVEREXPRESSION IN MEDULLOBLASTOMA

被引：0
|
作者：
Danis, Etienne [1 ]
Pierce, Angela [1 ]
Balakrishan, Ilango [1 ]
Wang, Dong [1 ]
Venkataraman, Sujatha [1 ]
Vibhakar, Rajeev [1 ]
机构：
[1] Univ Colorado Denver Anschutz Med Campus, Aurora, CO USA
来源：
NEURO-ONCOLOGY | 2018年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MBRS-48
引用
收藏
页码：138 / 138
页数：1
相关论文
共 50 条
  • [31] Targeting EZH2 for the treatment of soft tissue sarcomas
    Karolak, Magdalena
    Tracy, Ian
    Shipley, Janet
    Walters, Zoe S.
    JOURNAL OF CANCER METASTASIS AND TREATMENT, 2021, 7
  • [32] Targeting epigenetics in sarcomas through EZH2 inhibition
    Antoine Italiano
    Journal of Hematology & Oncology, 13
  • [33] Targeting EZH2 in acral lentiginous melanoma (ALM).
    Izsak, Allison
    Giles, Keith Michael
    Lui, Kevin Paul
    Weiss, Sarah A.
    Moran, Una
    de Miera, Eleazar Vega-Saenz
    Stein, Jennifer
    Lee, Ann Yeelin
    Darvishian, Farbod
    Shapiro, Richard L.
    Berman, Russell S.
    Pavlick, Anna C.
    Wilson, Melissa
    Osman, Iman
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [34] Targeting epigenetics in sarcomas through EZH2 inhibition
    Italiano, Antoine
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [35] EZH2 overexpression as a biomarker of poor prognosis in prostate cancer
    Gu, Xiaobin
    Gao, Xian-Shu
    Bai, Yun
    Cui, Ming
    Xiong, Wei
    Han, Linjun
    Guo, Wei
    Xie, Mu
    Peng, Chuan
    Su, Mengmeng
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (11): : 21829 - 21835
  • [36] EZH2 Overexpression as a Novel Prognostic Marker in Lung Adenocarcinoma
    Parimi, V.
    Raj, R.
    Chen, Y-H
    Raparia, K.
    MODERN PATHOLOGY, 2014, 27 : 490A - 490A
  • [37] EZH2 Overexpression as a Novel Prognostic Marker in Lung Adenocarcinoma
    Parimi, V.
    Raj, R.
    Chen, Y-H
    Raparia, K.
    LABORATORY INVESTIGATION, 2014, 94 : 490A - 490A
  • [38] EZH2 OVEREXPRESSION INCREASES THE ONCOGENIC CHARACTER OF CEREBELLAR PROGENITORS AND ISOGRAFTS IN MICE RESULT IN TUMORS RESEMBLING GROUP 3 MEDULLOBLASTOMA
    Sola, Ismail
    Venkataraman, Sujatha
    Pierce, Angela
    Balakrishnan, Ilango
    Birks, Diane
    Foreman, Nicholas K.
    Vibhakar, Rajeev
    NEURO-ONCOLOGY, 2018, 20 : 132 - 133
  • [39] Targeting EZH2 in SMARCB1-deficient sarcomas: Advances and opportunities to potentiate the efficacy of EZH2 inhibitors
    Lanzi, Cinzia
    Arrighetti, Noemi
    Pasquali, Sandro
    Cassinelli, Giuliana
    BIOCHEMICAL PHARMACOLOGY, 2023, 215
  • [40] Enhancer of Zeste Homologue 2 (EZH2) Expression Is Associated with Cell Proliferation in Medulloblastoma
    Shi, M.
    Qiu, J.
    Smith, T. W.
    Kilpatrick, D. L.
    Wang, W.
    MODERN PATHOLOGY, 2013, 26 : 418A - 418A
12345